SpyGlass Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SGP and other ETFs, options, and stocks.About SGP
SpyGlass Pharma, Inc. is a late-stage biopharmaceutical, which engages in the development of treatment paradigm for patients living with chronic eye conditions. Its lead product candidate, Bimatoprost Drug Pad-IOL System (BIM-IOL System), is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) for patients who have wither open-angel glaucoma (OAG) or ocular hypertension (OHT).
CEOPatrick Mooney
CEOPatrick Mooney
Employees—
Employees—
HeadquartersAliso Viejo, California
HeadquartersAliso Viejo, California
Founded2019
Founded2019
Employees—
Employees—
SGP Key Statistics
Market cap831.29M
Market cap831.29M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today$27.45
High today$27.45
Low today$20.16
Low today$20.16
Open price$24.00
Open price$24.00
Volume498.64K
Volume498.64K
52 Week high—
52 Week high—
52 Week low—
52 Week low—
Stock Snapshot
SpyGlass Pharma(SGP) stock is priced at $26.05, giving the company a market capitalization of 831.29M.
On 2026-02-06, SpyGlass Pharma(SGP) stock moved within a range of $20.16 to $27.45. With shares now at $26.05, the stock is trading +29.2% above its intraday low and -5.1% below the session's peak.
Trading volume for SpyGlass Pharma(SGP) stock has reached 498.64K.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.